For individuals with dominantly inherited Alzheimer disease, long-term treatment with gantenerumab may delay clinical decline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback